Skip to main content
. Author manuscript; available in PMC: 2022 Feb 1.
Published in final edited form as: Mol Carcinog. 2020 Dec 30;60(2):138–150. doi: 10.1002/mc.23275

FIGURE 5.

FIGURE 5

Association of CHK1 gene abundances with cancer-related biological pathways. (A) GSEA of hallmark pathways including immune-related prexasertib resistance signature, associated with CHK1-lo and CHK1-hi gene expression in the TCGA cohort. (B) Enrichment plot of E2F targets and immune-related prexasertib resistance signature in TCGA CHK1-hi and -lo groups. (C) The interactions of the genes in the immune-related prexasertib resistance signature as clustered by the STRING database.